MedCity and the KPBMA (Korean Pharmaceutical and BioPharma Manufacturers Association) will be hosting a joint webinar in mid-September on the Evolution of Immuno-Oncology. High profile speakers from the UK and Korea will be sharing their insights during this international collaborative event.
Further details coming shortly on speakers, final agenda, this event is open to all those working in advanced therapies. To find out more about joining the advanced therapies network please contact us or go to https://www.medcityhq.com/advanced-therapies-network/
The Advanced Therapies Network (ATN) aims to support networking opportunities and knowledge exchange between academic organisations, life sciences companies and investors in this area.